CBD products will soon be on the shelves of two mainstream US drugstore chains. CVS – one of the largest retail pharmacy chains in the US – is already selling a range of products in at least eight US states and Walgreens intends to sell products in nine states.
Restricted content. Do you want to read more?
Sign up NOW for 7 days FREE TRIAL and access our briefings section
CBD-Intel provides impartial, independent and premium market and regulatory analysis, legal tracking, and quantitative data for the cannabidiol (CBD) sector worldwide. Most content is available to subscribers only.